Understanding Valvular Heart Disorders: Regurgitation & Stenosis, Summaries of Medicine

An in-depth analysis of various valvular heart disorders, including tricuspid and mitral valve regurgitation and stenosis, as well as aortic valve regurgitation and stenosis. It covers the causes, clinical manifestations, medical and surgical management, and nursing management for each disorder.

Typology: Summaries

2023/2024

Available from 04/04/2024

US-Summery
US-Summery 🇮🇹

4.1

(22)

937 documents

1 / 11

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
lOMoARcPSD|39820385
S. Sheppard,
Management of patients
with structural infectious
and inflammatory cardiac
disorders
pf3
pf4
pf5
pf8
pf9
pfa

Partial preview of the text

Download Understanding Valvular Heart Disorders: Regurgitation & Stenosis and more Summaries Medicine in PDF only on Docsity!

lOMoARcPSD|

S. Sheppard,

Management of patients

with structural infectious

and inflammatory cardiac

disorders

Chapter 28 Management of Patients with Structural, Infectious, and Inflammatory Cardiac Disorders Valvular Disorders

  • Tricuspid valve : separates the right atrium from the right ventricle
  • Mitral valve: separates the left atrium from the left ventricle
  • Semilunar valves located between the ventricles and their corresponding arteries o Pulmonic valve: lies between the right ventricle and the aorta o Aortic valve: lies between the left ventricle and the aorta
  • Regurgitation: The valve does not close properly, and blood backflows through the valve
  • Stenosis: The valve does not open completely, and blood flow through the valve is reduced
  • Valve prolapse: The stretching of an atrioventricular valve leaflet into the atrium during diastole
  • Patients may not require treatment, or they may need to make lifestyle changes, take medications, or require surgical repair or replacement of valve.
  • Regurgitation and stenosis may occur at the same time in the same or different valves. Mitral Prolapse
  • A deformity that usually produces no symptoms
  • Rarely, it progresses and can result in sudden death.
  • The cause may be inherited connective tissue disorder resulting in enlargement of one or both mitral leaflet
  • A portion of one or both mitral valve leaflets balloons back into the atrium during systole.
  • About 15% of patients who develop murmurs eventually experience heart enlargement, A fib, pulmonary hypertension, or HF.
  • Clinical Manifestations o Most people don’t have symptoms o A few have fatigue, SOB, lightheadedness, dizziness, syncope, palpitations, chest pain or anxiety o Fatigue may occur regardless of activity level and amount of rest or sleep. o SOB is not correlated with activity levels or pulmonary function o Atrial or ventricular dysrhythmias may produce the sensation of palpitations o Pain is not correlated with activity and may last for days o Some symptoms may be explained by dysautonomia (a dysfunction of the autonomic nervous system that results in increased excretion of catecholamines)
  • Assessment and Diagnostic Findings o First and only sign of mitral valve prolapse is an extra heart sound (mitral click) o A systolic click is an early sign that a valve leaflet is ballooning into the left atrium o A murmur of mitral regurgitation may be heard if the valve opens during systole and blood flows back into the left atrium o Pt may experience symptoms of HF if mitral regurgitation occurs
  • The right ventricle also hypertrophies, eventually dilate, and fails.
  • The heart rate increases, cardiac output decreases and pulmonary pressures increase
  • most often caused by rheumatic endocarditis, which thickens mitral valve leaflets and chordae
  • leaflets often fuse together
  • Clinical Manifestations o First symptom of mitral stenosis is often dyspnea on exertion as a result of pulmonary venous hypertension o Patients may experience fatigue and decreased exercise tolerance o An enlarged left atrium may create pressure on the left bronchial tree, resulting in a dry cough or wheezing. o Pt may expectorate blood (hemoptysis) or experience palpitations, orthopnea, paroxysmal nocturnal dyspnea (PND), and repeated respiratory infections o As a result of increased blood volume and pressure, the atrium dilates, and becomes electrically unstable (pt experience atrial dysrhythmias.
  • Prevention o Minimize risk and treat bacterial infections o Prevention of acute rhematic fever depends on effective antibiotic treatment of group A streptococcal infection o Antibiotic prophylaxis for recurrent rheumatic fever with rheumatic carditis may requires 10 or more years of antibiotic coverage (Penicillin G IM every 4 weeks, penicillin V PO BID, sulfadiazine PO daily, or erythromycin PO BID)
  • Medical Management o Anticoagulants are used to decrease the risk of developing atrial thrombus and may require treatment for angina o If atrial fibrillation develops, cardioversion is attempted to restore normal sinus rhythm. o If unsuccessful, the ventricular rate is controlled with beta-blockers, digoxin, or calcium channel blockers o Avoid strenuous activities, competitive sports and pregnancy o Surgical intervention consists of valvuloplasty to open or rupture the fused commissures of the valve Aortic Regurgitation
  • The flow of blood back into the left ventricle from the aorta during diastole
  • may be caused by inflammatory lesions that deform aortic valve leaflets or dilation of the aorta, preventing complete closure of the aortic valve
  • this defect also may result from ineffective rheumatic endocarditis, congenital abnormalities, diseases such as syphilis, a dissecting aneurysm, blunt chest trauma, or deterioration of a surgically replaced aortic valve
  • Clinical manifestations o Aortic insufficiency develops without symptoms in most patients o Marked arterial pulsations visible or palpable at carotid or temporal arteries may be present as a result of increased force in volume of blood ejected from a hypertrophied left ventricle o Dyspnea on exertion, orthopnea, PND
  • Assessment o High-pitched blowing diastolic murmur is heard at the 3 rd^ or 4 th^ intercostal space of the left sternal border o Pulse pressure (difference btwn systolic and diastolic pressures) is widened o Characteristic sign is the water hammer (Corrigan’s) pulse, the pulse strikes a palpating finger with a quick, sharp stole and then suddenly collapses o Diagnoses confirmed by echocardiography (preferably transesophageal), cardiac magnetic resonance imaging (MRI), cardiac cath.
  • Medical Management o Symptomatic patient or patient with decreased left ventricular function, is advised to avoid physical exertion o Should be treated with dihydropyridine calcium channel blockers (felodipine, nifedipine) or ACE inhibitors (captopril, enalapril, lisinopril, ramipril) to provides afterload reduction o Restrict sodium and avoid fluid overload Aortic Stenosis
  • Narrowing of the orifice between the left ventricle and aorta
  • In adults, stenosis is a result of degenerative calcifications that may be caused by proliferative and inflammatory changes that occur from normal mechanical stress.
  • Age, diabetes, hypercholesterolemia, hypertension, smoking, and elevated levels of LDL cholesterol may be factors for degenerative calcific changes of the valve
  • Clinical Manifestations o Asymptomatic response if stenosis develops slowly – left ventricle compensates o Exertional dyspnea, orthopnea, PND, pulmonary edema, dizziness and syncope (decreased blood flow to brain), angina o BP may be normal or low. Pulse pressure may be low because of diminished blood flow
  • Assessment and Diagnostic findings o A loud, harsh systolic murmur may be heard over the aortic area (Right second intercostal space) and may radiate to the carotid arteries and the apex of the left ventricle o The murmur is low pitched, crescendo-decrescendo, rough rasping, and vibrating o S4 sound may be heard o Echocardiography, cardiac MRI, and CT scanning are used to diagnose and monitor
  • Medical Management o Surgical intervention (valve replacement, balloon valvuloplasty Nursing Management: Valvular Heart Disorders
  • Patient education
  • Monitor VS trends
  • Monitor for complications o Heart failure o Dysrhythmias

▪ Bleeding, thromboembolism, infection, heart failure, hypertension, dysrhythmias, hemolysis and mechanical obstruction of the valve o Mechanical valves: thought to be more durable than tissue prosthetic valves. ▪ Used for patients with kidney injury, hypercalcemia, endocarditis or sepsis ▪ Complications: thromboemoli and long-term anticoagulation therapy required o Tissue valves: less likely to generate thromboembolic and long-term anticoagulation is not required o Bioprosthesis are tissue valves (heterographs) used for aortic, mitral, and tricuspid valve replacement. ▪ Long-term anticoagulation not required ▪ Used for women of child-bearing age because potential complications of long-term anticoagulation associated with menses, placental transfer to a fetus and delivery of a child are avoided ▪ Most bioprostheses are from pigs (porcine), some from cows (bovine) or horses (equine) ▪ Viability is 7 to 15 yrs o Homografts or allografts (human valves) are obtained from a cadaver tissue donation and used for aortic and pulmonic valve replacement o Autografts (autologous valves) obtained by excising the patient’s own pulmonic valve and a portion of the pulmonary artery for use as the aortic valve ▪ Anticoagulation is unnecessary ▪ It is an alternative for children, women of childbearing age, young adults, pt with history of peptic ulcer disease, and people who cannot tolerate anticoagulation. Nursing Management: Valvuloplasty and Valve Replacement

  • Balloon Valvuloplasty o Monitor for heart failure and emboli o Assess heart sounds q4h o Same care as after cardiac catheterization
  • Surgical valvuloplasty or valve replacements o Focus is hemodynamic stability and recovery from anesthesia o Frequent assessments with attention to neurologic, respiratory, and cardiovascular systems
  • Patient education o Anticoagulation therapy o Prevention of infective endocarditis o Follow up o Repeat echocardiograms

Cardiomyopathy

  • Cardiomyopathy is a series of progressive events that culminates in impaired cardiac output and can lead to heart failure, sudden death, or dysrhythmias.
  • Types o Dilated cardiomyopathy (DCM) ▪ Most common cardiomyopathy ▪ Dilation of ventricles without hypertrophy ▪ Elevated volume, decreased ejection fraction ▪ Yields high end-diastolic pressure – higher pulmonary and systemic venous pressure o Hypertrophic cardiomyopathy (HCM) ▪ autosomal dominant condition ▪ family history of HCM critical factor ▪ ongoing monitoring of echocardiograms ▪ Increased risk of dysrhythmias (VT, VF) ▪ Restrict blood to myocardium o Restrictive/constrictive cardiomyopathy (RCM) ▪ Predominant diastolic dysfunction ▪ Dyspnea, nonproductive cough, chest pain, echocardiography, arterial and venous pressure measurements o Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) o Unclassified cardiomyopathy
  • Clinical manifestations o Patients may remain stable and without symptoms for many years. o Dilated and restrictive cardiomyopathy is first diagnosed when the patient presents with s&s of heart failure (DOE, fatigue) o May report PND, cough, orthopnea o Fluid retention, peripheral edema, and nausea o Chest pain, palpitations, dizziness, nausea and syncope on exertion
  • Nursing Process: Nursing diagnoses o Decreased cardiac output o Risk for ineffective cardiac, cerebral, peripheral, and renal tissue perfusion o Impaired gas exchange o Activity intolerance o Anxiety o Powerlessness o Noncompliance with medication and diet therapies
  • Collaborative Problems and potential complications o Heart failure o Ventricular dysrhythmias o Atrial dysrhythmias o Cardiac conduction defects o Pulmonary or cerebral embolism o Valvular dysfunction
  • Nursing Process: Planning and Goals

Infectious Diseases of the Heart

  • Any of the layers of the heart may be affected by an infectious process
  • Infections are named by the layer of the heart that is affected
  • Diagnosis is made by patient symptoms and echocardiogram
  • Management of all infectious diseases is prevention
  • IV antibiotics usually are necessary once an infection has developed in the heart
  • Rheumatic endocarditis o Occurs most often in school-age children after group A beta-hemolytic streptococcal pharyngitis; need to promptly recognize and treat “strep” throat to prevent rheumatic fever
  • Infective endocarditis o Usually develops in people with prosthetic heart valves or structural cardiac defects; also occurs in patients who are IV drug abusers and in those with debilitating diseases, indwelling catheters, or prolonged IV therapy o Clinical manifestations ▪ Primary symptoms are fever and heart murmur ▪ Clusters of petechiae may be found on the body ▪ Small, painful nodules (Osler nodes) may be present in pads of fingers and toes ▪ Irregular, red or purple, painless flat macules (Janeway lesions) may be present on palms, fingers, hands, soles, and toes ▪ Hemorrhages with pale centers (Roth spots) caused by emboli may be observed in the fundi of the eyes. ▪
  • Pericarditis o Inflammation of the pericardium; many causes; potential complications: pericardial effusion and cardiac tamponade o Pain or discomfort usually remains fairly constant, but it may worsen with deep inspiration and when lying down or turning. o Medical management ▪ Impaired cardiac output = bed rest ▪ NSAIDs such as aspirin and ibuprofen are prescribed for pain ▪ Colchicine or corticosteroids (prednisone) for severe pericarditis
  • Myocarditis o An inflammatory process involving the myocardium; most common pathogens involved in myocarditis tend to be viral; in endocarditis, they tend to be bacterial; complications: cardiomyopathy and heart failure ▪ Medical management - Treat underlying cause if it is known (penicillin for hemolytic streptococci) and - Placed on bed rest to decrease cardiac workload - In young patients, activities should be limited for a 6 - month period or until heart has returned to normal size - Physical activity is slowly increased, advised to report any symptoms with activity
  • NSAIDS should not be used, could make it worse!
  • Clinical manifestations o Fever o New heart murmur, friction rub at left lower sternal border, chest pain (pericarditis) o Osler nodes, Janeway lesions, Roth spots, and splinter hemorrhages in nailbeds (rheumatic) o Cardiomegaly, heart failure, tachycardia, splenomegaly (endocarditis) o Fatigue, dyspnea, syncope, palpitations, chest pain (myocarditis) o Diagnostic tools : blood cultures, echocardiogram, CBC, rheumatoid factor, ESR, CRP, urinalysis, ECG, cardiac catheterization, CMR imaging, TEE, CT scan
  • Prevention o Antibiotic prophylaxis before certain procedures o Ongoing oral hygiene o Female patients are advised NOT to use IUDs o Meticulous care should be taken in patients “at risk” who have catheters o Catheters should be removed as soon as they are no longer needed o Immunizations